DK1778834T3 - Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser - Google Patents

Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser

Info

Publication number
DK1778834T3
DK1778834T3 DK04777586.1T DK04777586T DK1778834T3 DK 1778834 T3 DK1778834 T3 DK 1778834T3 DK 04777586 T DK04777586 T DK 04777586T DK 1778834 T3 DK1778834 T3 DK 1778834T3
Authority
DK
Denmark
Prior art keywords
methods
disorders
treatment
patient
renal diseases
Prior art date
Application number
DK04777586.1T
Other languages
English (en)
Other versions
DK1778834T5 (da
Inventor
Marc H Hedrick
John K Fraser
Eric Daniels
Original Assignee
Cytori Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytori Therapeutics Inc filed Critical Cytori Therapeutics Inc
Application granted granted Critical
Publication of DK1778834T3 publication Critical patent/DK1778834T3/da
Publication of DK1778834T5 publication Critical patent/DK1778834T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04777586.1T 2004-07-01 2004-07-01 Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser DK1778834T5 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/021549 WO2006014162A2 (en) 2004-07-01 2004-07-01 Methods of using regenerative cells in the treatment of renal diseases and disorders

Publications (2)

Publication Number Publication Date
DK1778834T3 true DK1778834T3 (da) 2010-11-29
DK1778834T5 DK1778834T5 (da) 2012-01-09

Family

ID=35787532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04777586.1T DK1778834T5 (da) 2004-07-01 2004-07-01 Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser

Country Status (6)

Country Link
EP (1) EP1778834B9 (da)
AT (1) ATE478942T1 (da)
DE (1) DE602004028876D1 (da)
DK (1) DK1778834T5 (da)
ES (1) ES2351341T3 (da)
WO (1) WO2006014162A2 (da)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10589268B2 (en) 2016-06-08 2020-03-17 The Regents Of The University Of California Method and device for processing tissues and cells
US10683480B2 (en) 2013-06-21 2020-06-16 The Regents Of The University Of California Microfluidic tumor tissue dissociation device and method
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074316A2 (de) * 2006-12-21 2008-06-26 B. Braun Medizintechnologie Gmbh Verfahren zur steuerung einer vorrichtung zur extrakorporalen blutbehandlung und vorrichtung zur extrakorporalen blutbehandlung
CN105013032B (zh) 2014-03-31 2018-06-22 甘布罗伦迪亚股份公司 体外血液处理***及用于该***的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
RU2331668C2 (ru) * 2001-11-09 2008-08-20 Артесел Сайенсиз, Инк. Стромальные клетки, полученные из жировой ткани, для заживления дефектов роговицы и внутриглазных дефектов и их использование
EP2308963A3 (en) * 2001-12-07 2011-09-21 Cytori Therapeutics, Inc. System for processing lipoaspirate cells
CN1842589B (zh) * 2003-06-25 2012-04-25 马克罗珀尔生物外科公司 用于从组织分离并且浓缩再生细胞的***和方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10683480B2 (en) 2013-06-21 2020-06-16 The Regents Of The University Of California Microfluidic tumor tissue dissociation device and method
US11427798B2 (en) 2013-06-21 2022-08-30 The Regents Of The University Of California Microfluidic tissue dissociation device and method
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
US10589268B2 (en) 2016-06-08 2020-03-17 The Regents Of The University Of California Method and device for processing tissues and cells
US11130127B2 (en) 2016-06-08 2021-09-28 The Regents Of The University Of California Method and device for processing tissues and cells

Also Published As

Publication number Publication date
WO2006014162A2 (en) 2006-02-09
ATE478942T1 (de) 2010-09-15
ES2351341T3 (es) 2011-02-03
EP1778834B1 (en) 2010-08-25
DK1778834T5 (da) 2012-01-09
EP1778834B9 (en) 2011-11-09
WO2006014162A3 (en) 2006-03-23
DE602004028876D1 (de) 2010-10-07
EP1778834A2 (en) 2007-05-02
EP1778834A4 (en) 2007-09-05
ES2351341T9 (es) 2012-02-14

Similar Documents

Publication Publication Date Title
DK1885382T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af cardiovaskulære tilstande
DK1599575T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af kardiovaskulære tilstande
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
DK1778833T3 (da) Fremgangsmåder til anvendelse af regenerative celler til at fremme sårheling
EA200971053A1 (ru) Способы лечения кожных язв
AR109103A1 (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BRPI0418745A (pt) anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente
BR112018072714A2 (pt) composições de ligação a hcl para e método de tratamento de distúrbios de ácido-base
EA201001749A1 (ru) Способ лечения недифференцированного артрита
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
EA200600921A1 (ru) Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний
EA201290278A1 (ru) Способ лечения сердечной недостаточности с использованием стресскопинподобных пептидов
EA201591522A1 (ru) Лечение реакции трансплантат против хозяина у подвергаемых трансплантации пациентов
DK1778834T3 (da) Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser
GB0405381D0 (en) A method and means for treating heart failure
WO2020061067A3 (en) Compositions and methods for treating bone injury
MX2022015109A (es) Tratamiento de homocistinuria e hiperhomocisteinemia mediante el uso de cistationina-gamma-liasa.
UA116484U (uk) Cпосіб лікування артеріальної гіпертензії з метаболічним синдромом
ATE526984T1 (de) Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen
UA6522U (en) Method for treating patients with multiple and combined injuries of long bones
RU2010145617A (ru) Способ лечения больных с черепно-мозговой травмой на фоне гипертензионного синдрома в острый период
UA93054U (uk) Спосіб негайної дентальної імплантації з використанням аутоплазми, збагаченої факторами росту людини, та повідон-йоду
UA37078U (ru) Способ профилактики рефлюкс-холангита при хирургическом лечении больных с механической желтухой